Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Xueqin Shang
LncRNA TATDN1 Contributes to the Cisplatin Resistance of Non-Small Cell Lung Cancer Through TATDN1/miR-451/TRIM66 Axis
Cancer Biology and Therapy
Cancer Research
Oncology
Molecular Medicine
Pharmacology
Related publications
LncRNA SNHG12 Contributes to Multidrug Resistance Through Activating the MAPK/Slug Pathway by Sponging miR-181a in Non-Small Cell Lung Cancer
Oncotarget
Oncology
The lncRNA LINC01194/miR-486-5p Axis Facilitates Malignancy in Non-Small Cell Lung Cancer via Regulating CDK4
OncoTargets and Therapy
Oncology
Pharmacology
AFAP1‑AS1 Induces Cisplatin Resistance in Non‑small Cell Lung Cancer Through PI3K/AKT Pathway
Oncology Letters
Cancer Research
Oncology
Upregulated lncRNA SNHG1 Contributes to Progression of Non-Small Cell Lung Cancer Through Inhibition of miR-101-3p and Activation of WNT/Β-Catenin Signaling Pathway
Oncotarget
Oncology
The Low Expression of miR-451 Predicts a Worse Prognosis in Non-Small Cell Lung Cancer Cases
PLoS ONE
Multidisciplinary
TopBP1 Contributes to the Chemoresistance in Non-Small Cell Lung Cancer Through Upregulation of P53
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
miR-1269b Drives Cisplatin Resistance of Human Non-Small Cell Lung Cancer via Modulating the PTEN/PI3K/AKT Signaling Pathway
OncoTargets and Therapy
Oncology
Pharmacology
miR-181 Regulates Cisplatin-Resistant Non-Small Cell Lung Cancer via Downregulation of Autophagy Through the PTEN/PI3K/AKT Pathway
Oncology Reports
Medicine
Cancer Research
Oncology
LncRNA NEAT1 Exacerbates Non-Small Cell Lung Cancer by Upregulating EIF4G2 via miR-582-5p Sponging
Archives of Biological Sciences
Biochemistry
Agricultural
Genetics
Molecular Biology
Biological Sciences
